Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

November 18, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • An aid to the pandemic: Development of the low-cost, highly efficient ventilator by UK scientists

COVID-19 Project Recruitment at CSIR-IHBT | Applications Invited

CSIR-IICT COVID-19 Project Recruitment | Rs. 56,000 pm Salary

An aid to the pandemic: Development of the low-cost, highly efficient ventilator by UK scientists
  • BiotechToday
  • World

An aid to the pandemic: Development of the low-cost, highly efficient ventilator by UK scientists

bioxone January 6, 2021January 6, 2021

Ayooshi Mitra, Amity University, Kolkata

A small but important aspect of managing a pandemic virus infection that affects the lungs, including SARS-CoV-1, SARS-CoV-2 (COVID-19), and influenza, is mechanical ventilation. Generally, ventilators are costly, difficult to maintain, and need considerable training to use. The majority of ventilators rely on high-flow oxygen and medically pure compressed air supplies, which are not always readily available in many countries across the world.

Recently, scientists from the United Kingdom were awarded funding to develop a robust, low-cost ventilator to help patients suffering from severe respiratory problems due to COVID-19, in low and middle-income countries. A team of researchers, coordinated by the Daresbury Laboratory of the Science and Technology Facilities Council (STFC), aims to develop and test plans for the implementation of an affordable, safe, and easy-to-use ventilator that does not rely exclusively on compressed gases and the supply of electricity to the power system. This project, referred to as the High-Performance Low-Cost Ventilator (HPLV), has been constructed on the original HEV (High Energy Physics Ventilator) designs developed during the first lockdown at CERN. The team for HEV and HPLV will be working in coordination with international partners from the Federal University of Rio de Janeiro (Brazil) as well as the University of Birmingham, the University of Liverpool, and the Medical Devices Testing and Evaluation Centre (MDTEC), to develop a ventilator focused on quality and patient comfort. The project will run for six months between October 2020 and April 2021, with a small percentage of funding to support the transfer of HPLV technology to industrial partners, over the next 12 months.

Also read:Remdesivir resistant SARS-CoV-2!

Reference: https://scitechdaily.com/uk-scientists-to-produce-low-cost-high-performance-ventilators/

Picture Credit: CERN

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged CERN COVID-19 influenza low-cost ventilator pandemic SARS-CoV-1 SARS-CoV-2 UK university of Liverpool ventilation ventilator virus

One thought on “An aid to the pandemic: Development of the low-cost, highly efficient ventilator by UK scientists”

  1. Pingback: BRAIN FOG: A temporary post-COVID-19 brain disorder - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

CSIR-IICT COVID-19 Project Recruitment | Rs. 56,000 pm Salary

bioxone January 6, 2021

-Shristi Sharma, Team bioXone CSIR-IICT Vacancies 2021 – Online Application Process. MSc/MTech/PhD Biotechnology, Biochemistry, Microbiology and Molecular Biology Jobs. Interested and eligible applicants can check out all of the details on the same below:  CSIR – INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY [Council of Scientific & Industrial Research] Hyderabad – 500 007 NOTIFICATION NO. 01/2021 FOR […]

Related Post

  • BiotechToday
  • World

Multi-angle projection microscope: A Novel Imaging Technique

BioTech Today July 2, 2021July 1, 2021

Agrima Bhatt, Rajasthan University As students of life sciences, we have always been told to first inspect carefully then ask questions. Inspecting at an early age takes a lot of patience, still, we held our specimen under the microscope, corrected the alignment of light, turned and tried to understand coarse and fine adjustment, then saw […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Protrudin supports axon regeneration in the adult CNS

bioxone November 6, 2020November 6, 2020

Saptaparna Pal, Amity University Kolkata Axons of the adult peripheral nervous system(PNS) and immature central nervous system (CNS) neurons readily regenerate after injury. In addition to the non-permissive extracellular environment after injury, the intrinsic neuronal factors also play an important role in the regenerative failure that is observed in mature CNS neurons. Protrudin acts as […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

New Acyl CoA synthetase 4 inhibitor reduces breast and prostate tumour growth

bioxone October 19, 2020October 19, 2020

Rohit Bhattacharjee, Amity University Kolkata Acyl CoA synthetase 4 (ACSL4) is an isoenzyme of the fatty acid ligase-coenzyme A family that takes part in arachidonic acid metabolism and steroidogenesis. ACSL4 is involved in tumour aggressiveness in breast and prostate tumours through various signal transduction pathways regulation. A well-validated ACSL4 inhibitor, however, has not been reported […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy